These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35449229)

  • 21. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.
    Lee J; Kim HS; Cho YK; Kim EH; Lee MJ; Bae IY; Jung CH; Park JY; Kim HK; Lee WJ
    Sci Rep; 2020 Oct; 10(1):18323. PubMed ID: 33110139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
    Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
    PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
    Boursier J; Guillaume M; Leroy V; Irlès M; Roux M; Lannes A; Foucher J; Zuberbuhler F; Delabaudière C; Barthelon J; Michalak S; Hiriart JB; Peron JM; Gerster T; Le Bail B; Riou J; Hunault G; Merrouche W; Oberti F; Pelade L; Fouchard I; Bureau C; Calès P; de Ledinghen V
    J Hepatol; 2019 Aug; 71(2):389-396. PubMed ID: 31102719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients.
    Raggi P; Zona S; Scaglioni R; Stentarelli C; Ligabue G; Besutti G; Menozzi M; Santoro A; Malagoli A; Bellasi A; Guaraldi G
    J Cardiovasc Comput Tomogr; 2015; 9(6):553-8. PubMed ID: 26310588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study.
    Cosson E; Nguyen MT; Rezgani I; Berkane N; Pinto S; Bihan H; Tatulashvili S; Taher M; Sal M; Soussan M; Brillet PY; Valensi P
    Cardiovasc Diabetol; 2021 Nov; 20(1):224. PubMed ID: 34819079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.
    Hsiao CC; Teng PH; Wu YJ; Shen YW; Mar GY; Wu FZ
    BMC Cardiovasc Disord; 2021 May; 21(1):244. PubMed ID: 34011282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    Kim G; Kim KJ; Rhee Y; Lim SK
    PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    Hernández-Conde M; Llop E; Carrillo CF; Tormo B; Abad J; Rodriguez L; Perelló C; Gomez ML; Martínez-Porras JL; Puga NF; Trapero-Marugan M; Fraga E; Aracil CF; Panero JLC
    World J Gastroenterol; 2020 Nov; 26(42):6658-6668. PubMed ID: 33268953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study.
    Cosson E; Nguyen MT; Rezgani I; Tatulashvili S; Sal M; Berkane N; Allard L; Brillet PY; Bihan H
    Cardiovasc Diabetol; 2021 Feb; 20(1):35. PubMed ID: 33546697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
    Song DS; Chang UI; Kang SG; Song SW; Yang JM
    Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of vascular stiffness with epicardial and pericardial adipose tissues, and coronary atherosclerosis.
    Choi TY; Ahmadi N; Sourayanezhad S; Zeb I; Budoff MJ
    Atherosclerosis; 2013 Jul; 229(1):118-23. PubMed ID: 23537929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.
    Jaruvongvanich V; Wirunsawanya K; Sanguankeo A; Upala S
    Dig Liver Dis; 2016 Dec; 48(12):1410-1417. PubMed ID: 27697419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease.
    Mikolasevic I; Orlic L; Milic S; Lukenda V; Racki S; Stimac D; Avdovic E; Zaputovic L
    Wien Klin Wochenschr; 2014 Aug; 126(15-16):474-9. PubMed ID: 24652022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep Learning-Based Quantification of Epicardial Adipose Tissue Volume and Attenuation Predicts Major Adverse Cardiovascular Events in Asymptomatic Subjects.
    Eisenberg E; McElhinney PA; Commandeur F; Chen X; Cadet S; Goeller M; Razipour A; Gransar H; Cantu S; Miller RJH; Slomka PJ; Wong ND; Rozanski A; Achenbach S; Tamarappoo BK; Berman DS; Dey D
    Circ Cardiovasc Imaging; 2020 Feb; 13(2):e009829. PubMed ID: 32063057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
    Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
    Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.